@article {130, title = {Antipsychotic medication therapy during the holy month of Ramadan: a literature review}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {July 2019}, pages = {79-83}, type = {Review Article}, chapter = {79}, abstract = {

Objectives: To review the antipsychotic medication therapy during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. The search on antipsychotic and anti-epileptic medication list and switch from regular days to Ramadan days included comparative safety, efficacy and cost of type of medication for each disease and national or international evidencebased guidelines including those switching short half-life to long half-life drugs. All nonoral dosage form of medication will be excluded in this study. All medications should be documented in the Ministry of Health drug formulary. Results: A total of 710 studies were shortlisted after an extensive search with specific terms. Of those, 104 studies were duplicate studies; therefore only 606 studies were included for further evaluation. The evaluation revealed that 27 studies discussed about the antipsychotic medications and Ramadan. Of these, only five were appropriate for further revision. According to our results, most of the studies were observational studies and a few have conducted experimental design studies. Three studies have a shared or similar study design (i.e., reports). Among all the reports analyzed in this study, most of them used study design. On the contrary, three studies mentioned the utilization of a descriptive approach; however, none of the studies mentioned the exact type of descriptive analysis conducted. One study was a clinical review and another study mentioned the applicability of a randomized controlled trial. Based on this, the authors suggested switching the antipsychotic and anti-epileptic medication from regular days to Ramadan days. Conclusion: There are no randomized clinical trials in the literature to validate the switching of medication from regular to Ramadan days. A list of antipsychotic medications that can be used to switch during Ramadan is highly warranted. Further studies to validate the medication used to treat psychiatric conditions during the holy month of Ramadan is recommended.

}, keywords = {Antipsychotic, Medication, Ramadan, Review, Therapy}, doi = {10.5530/PTB.2019.5.14}, author = {Yousef Ahmed Alomi and Jude Alhowaidi and Raneem Alzeer and Ali Alhowaidi and Nora Alhowaidi} } @article {128, title = {Cardiovascular medication therapy during the holy month of Ramadan: a literature review}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {July 2019}, pages = {69-74}, type = {Review Article}, chapter = {69}, abstract = {

Objectives: To review cardiovascular medication therapy during the Holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The list of cardiovascular medications and switch from regular days to Ramadan days based on literature revealed that{\textquoteright}s included comparative safety studies, efficacy and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life to long half-life. All parenteral dosage form of medication were excluded from this study. All medications should be listed in the Ministry of Health drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that there were 30 studies published on cardiovascular medications and Ramadan. Seven studies were further evaluated. The authors recommend to have a list of cardiovascular medications that can be switched from regular days to Ramadan days. Conclusion: There were very studies about cardiovascular medications use during the holy month of Ramadan. Suggested usage of the frequency administration single or twice daily is required during fasting. Future investigations of cardiovascular medication intake during Ramadan is highly recommended in Muslim countries.

}, keywords = {Cardiovascular, Medication, Review, Therapy}, doi = {10.5530/PTB.2019.5.12}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar} } @article {129, title = {Drug therapy for chronic diseases during the holy month of Ramadan: a literature review}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {July 2019}, pages = {75-78}, type = {Review Article}, chapter = {75}, abstract = {

Objectives: In this study, we aimed to review the drug therapy for chronic diseases during the holy month of Ramadan. Methods: In this study, we conducted an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. Medication list related to the gastrointestinal tract diseases, asthma and rheumatoid arthritis and the switch from regular days to Ramadan days revealed comparative safety, efficacy studies, cost of type of medication for each disease studies and national or international evidence based guidelines of switching short halflife to long half-life. All parenteral dosage form of medication were excluded from the analysis. All medications should be listed in the MOH drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that 27 studies investigated medications related to the gastrointestinal diseases and Ramadan and 15 studies were about medicines for asthma and rheumatoid arthritis and Ramadan. Of those 42 studies of Ramadan and chronic diseases, only 5 studies were found to be appropriate for further evaluation. The suggested draft of list of medications of chronic diseases from regular days to the Ramadan days is explored in the review. Conclusion: The guidelines medications of chronic disease (Asthma, RA, GIT disease) intake during the holy month of Ramadan is not found. The studies of drug schedules in Ramadan does not exist. The investigations about medications therapy of chronic disease are highly recommended in Muslim countries.

}, keywords = {Chronic diseases, Drug, Literature, Ramadan, Review, Therapy}, doi = {10.5530/PTB.2019.5.13}, author = {Yousef Ahmed Alomi and Ban Abdullah Aldosary and Nasser Faleh Aldawas and Rana Mohammed Alslim} } @article {127, title = {Intake of antibiotics and fasting during the holy month of Ramadan: A Literature Review}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {July 2019}, pages = {65-68}, type = {Review Article}, chapter = {65}, abstract = {

Objectives: To review the intake of antibiotics and fasting during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases following the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language with human study only for update May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The list of antibiotic medication and switch from regular days to Ramadan days based on literature search revealed comparative safety studies, efficacy studies and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life to long halflife. All parenteral dosage form of medication were excluded from study. All medications should be listed in the Ministry of Health drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 were considered for further evaluation. After evaluation, we obtained 30 studies which discussed about the antibiotics and Ramadan. Of these 30 studies, only 2 studies were found to be appropriate for further revision. Among the two, one study was an observational study regarding the pattern of prescribing antibiotics during the holy month of Ramadan. The second study was about the systemic review on the safety of fasting and several infectious diseases. The suggested draft of list of antibiotic switch from regular days to the holy Ramadan days was explored in this review. Conclusion: The investigations about antibiotics intake during fasting not found. The studies of antibiotic during the holy month of Ramadan is required during legal registrations at all Muslim countries. Antibiotics switch therapy during fasting is highly recommended at all Muslim patients in the world.

}, keywords = {Antibiotics, Fasting, Literature, Ramadan, Review}, doi = {10.5530/PTB.2019.5.11}, author = {Yousef Ahmed Alomi and Mohammed Abdulaziz Altuwaijri and Mohsen Huraybie Alshammari and Nouf Hameed Al-Muallad} }